HTHT [China Lodging,] 6-K: Contact Information Ida Yu Investor Relations Manager Tel:

[Contact Information Ida Yu Investor Relations Manager Tel: 86 (21) 6195 9561 ir@htinns.com Email: http://ir.htinns.com China Lodging, Limited Announces Preliminary Hotel Operating Results for First Quarter of 2012 Shanghai, China, April 6, 2012 China Lodging, Limited (NASDAQ: HTHT) (China Lodging or thempany), a leading and high-growth limited-service hotel chain operator in China, today announced preliminary] [Contact Information Ida Yu Investor Relations Manager Tel: 86 (21) 6195 9561 ir@htinns.com Email: http://ir.htinns.com China Lodging, Limited Appoints New Chief Operating Officer . Shanghai, China, April 6, 2012 China Lodging, Limited (NASDAQ: HTHT) (China Lodging or thempany), a leading and high-growth limited-service hotel chain operator in China, today announced the appointment of Yunhang Xie]

By | 2016-02-07T11:41:01+00:00 April 6th, 2012|Categories: Chinese Stocks, HTHT, Webplus ver|Tags: , , , , , |0 Comments

LFC [CHINA LIFE INSURANCE CO] 6-K: Stock Code: 2628 Annual Report 2011 The Company

[Stock Code: 2628 Annual Report 2011 The Company is the largest life insurance company in China. Our distribution network, comprising exclusive agents, direct sales representatives, and dedicated and non-dedicated agencies, is the most extensive one in China. The Company is one of the largest institutional investors in China, and through its controlling shareholding in China Life Asset Management Company Limited,] [Description 99.1 Annual Report, dated April 4, 2012]

By | 2016-03-28T06:49:08+00:00 April 6th, 2012|Categories: Chinese Stocks, LFC, Webplus ver|Tags: , , , , , |0 Comments

SNP [CHINA PETROLEUM & CHEMICAL] 6-K: (Original Filing)

[FORM 6-K CHINA PETROLEUM & CHEMICAL CORPORATION 22 Chaoyangmen North Street, Chaoyang District, Beijing, 100728 People's Republic of China Tel: (8610) 59960114 Form 20-F ü Form 40-F Yes No ü N/A This Form 6-K consists of: This announcement appears for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for securities of the]

By | 2016-04-01T11:45:52+00:00 April 6th, 2012|Categories: Chinese Stocks, SEC Original, SNP|Tags: , , , , , |0 Comments

BORN [CHINA NEW BORUN] 20-F: CHINA NEW BORUN CORPORATION TABLE OF CONTENTS INTRODUCTION

[CHINA NEW BORUN CORPORATION TABLE OF CONTENTS INTRODUCTION 4 5] [No: 23060500-2011 Nian Qing Ying Di Zi No. 0014 THE MORTGAGE CONTRACT AGRICULTURAL DEVELOPMENT BANK OF CHINA Mortgagor (in full): Daqing Borun Biotechnology Co., Ltd Business License Number: 230606100202956 Legal Representative (Main Responsible Officer): Wang Jinmiao Address: Jubao Village, Zhusan Township, Datong District, Daqing Postal code: 163515 Bank of Basic Deposit Account and Account Number: Daqing Datong Branch of Longjiang] [Contract No. Zhong Lv Bao Zhi Zi 2011 No. 009-2 Counter Security Pledge Contract Daqing Borun Biotechnology Co., Ltd. Pledger (Party A): Zhong Lv Credit Guarantee Co., Ltd. Pledgee (Party B): Daqing Borun Biotechnology Co., Ltd. Pledger: Address: Jubao Village, Zhusan County, Datong District, Daqing Municipality, Heilongjiang Province Legal representative: WANG Jinmiao Contact phone number: 0536-54556688 Fax: Zhong Lv Credit] [No.: Zhong Lv Bao Di Zi 2011 [009-2] Counter-Guarantee (Mortgage) Agreement Mortgagor (Party A): Daqing Borun Biotechnology Co., Ltd. Mortgagee (Party B): Zhong Lv Credit Guarantee Co., Ltd. Counter-Guarantee (Mortgage/Pledge) Agreement Mortgagor (Party A): Daqing Borun Biotechnology Co., Ltd. Mortgagee (Party B): Zhong Lv Credit Guarantee Co., Ltd. Daqing Borun Biotechnology Co., Ltd. the Debtor Daqing Branch of Agricultural Development] [Year 2011 Dongjianzi No. 011 Agreement No.: Commodity Financing Pledge Supervision Agreement (For rolling pledge) INDUSTRIAL AND COMMERCIAL BANK OF CHINA CO., LTD. CHINA NATIONAL FOREIGN TRADE TRANSPORTATION (GROUP) Party A (pledgee): Industrial and Commercial Bank of China Co., Ltd. Daqing Branch Address: No. 37, Dongfeng Road Saertu District, Daqing Party B (pledgor): Daqing Borun Biotechnology Co., Ltd. Domicile (address):] [CERTIFICATIONS I, Jinmiao Wang, certify that: 1. I have reviewed this annual report on Form 20-F of China New Borun Corporation (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATIONS I, Yuanqin (Terence) Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China New Borun Corporation (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATIONS (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jinmiao Wang Chairman and Chief Executive Officer] [CERTIFICATIONS (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Yuanqin (Terence) Chen Chief Financial Officer] [Consent of Independent Registered Public Accounting Firm China New Borun Corporation Shandong, China We hereby consent to the incorporation by reference in Registration Statement on Form F-1 (File No. 333-166312) of our report dated April 6, 2012, relating to the consolidated financial statements of China New Borun Corporation appearing in the Company’s Annual Report on Form 20-F for the year] [Consent of Independent Registered Public Accounting Firm China New Borun Corporation Shandong, China We hereby consent to the incorporation by reference in Registration Statement on Form F-1 (File No. 333-166312) of our report dated March 16, 2011, relating to the consolidated financial statements of China New Borun Corporation appearing in the Company’s Annual Report on Form 20-F for the year]

By | 2016-04-02T15:00:21+00:00 April 6th, 2012|Categories: BORN, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Unaudited Fourth Quarter and Preliminary Full Year 2011 Financial Results - Conference call scheduled for Thursday, March 29, 2012 at 8:00 AM EDT - BEIJING, March 29, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and preliminary full year financial results for the period] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F ¨ SINOVAC BIOTECH LTD. 6-K 1 v308765_6k.htm 6-K]

By | 2016-03-24T01:15:25+00:00 April 6th, 2012|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited Fourth Quarter and Preliminary Full

[Sinovac Reports Unaudited Fourth Quarter and Preliminary Full Year 2011 Financial Results - Conference call scheduled for Thursday, March 29, 2012 at 8:00 AM EDT - BEIJING, March 29, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and preliminary full year financial results for the period] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F ¨ SINOVAC BIOTECH LTD. 6-K 1 v308765_6k.htm 6-K]

By | 2016-03-24T01:17:32+00:00 April 6th, 2012|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Announces Director Appointment BEIJING, March 29, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today the appointment of Mr. Meng Mei as an independent director to fill the vacancy created by the resignation of Ms. Chup Hung Mok. Mr. Mei has also been appointed as the chairman of Sinovac's compensation] [Sinovac's EV71 Vaccine Phase I Clinical Data for the Prevention of Epidemic Hand, Foot, Mouth Disease Published in Vaccine Vaccine BEIJING, March 29, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that the positive Phase I clinical data for its proprietary inactivated Enterovirus 71 (EV71) vaccine against hand, foot and] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F ¨ SINOVAC BIOTECH LTD. 6-K 1 v301323_6k.htm FORM 6-K]

By | 2016-03-24T01:19:10+00:00 April 6th, 2012|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Announces Director Appointment BEIJING, March 29, 2012

[Sinovac Announces Director Appointment BEIJING, March 29, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today the appointment of Mr. Meng Mei as an independent director to fill the vacancy created by the resignation of Ms. Chup Hung Mok. Mr. Mei has also been appointed as the chairman of Sinovac's compensation] [Sinovac's EV71 Vaccine Phase I Clinical Data for the Prevention of Epidemic Hand, Foot, Mouth Disease Published in Vaccine Vaccine BEIJING, March 29, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that the positive Phase I clinical data for its proprietary inactivated Enterovirus 71 (EV71) vaccine against hand, foot and] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F ¨ SINOVAC BIOTECH LTD. 6-K 1 v301323_6k.htm FORM 6-K]

By | 2016-03-24T01:20:47+00:00 April 6th, 2012|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

CTC [IFM Investments] F-6 POS: (Original Filing)

[____________________ POST-EFFECTIVE AMENDMENT NO.2 TO FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 For Depositary Shares Evidenced by American Depositary Receipts IFM INVESTMENTS LIMITED N/A The Cayman Islands (Jurisdiction of incorporation or organization of issuer) JPMORGAN CHASE BANK, N.A. (Exact name of depositary as specified in its charter) 1 Chase Manhattan Plaza, Floor 21, New York, NY, 10005-1401] [Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A. represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (IFM Investments Limited, 333-164239) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. (2) That its ability to designate the date and time]

CTC [IFM Investments] F-6 POS: ____________________ POST-EFFECTIVE AMENDMENT NO.2 TO FORM F-6 REGISTRATION

[____________________ POST-EFFECTIVE AMENDMENT NO.2 TO FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 For Depositary Shares Evidenced by American Depositary Receipts IFM INVESTMENTS LIMITED N/A The Cayman Islands (Jurisdiction of incorporation or organization of issuer) JPMORGAN CHASE BANK, N.A. (Exact name of depositary as specified in its charter) 1 Chase Manhattan Plaza, Floor 21, New York, NY, 10005-1401] [Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A. represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (IFM Investments Limited, 333-164239) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. (2) That its ability to designate the date and time]

Skip to toolbar